Join us at The Festival of Genomics & Biodata in January
1/24/24
Offline
London, United Kingdom
Share
MGI Tech will be thrilled to announce its participation in The Festival of Genomics & Biodata, set to take place at ExCeL in London from Wednesday, January 24th, to Thursday, January 25th, 2024. We will invite you to join us at booth number 98 for a transformative experience.
Be sure to mark your calendars and join us for this exciting event. Visit here for more details and to register. We are looking forward to connecting with you at The Festival of Genomics & Biodata, where groundbreaking discoveries and collaborations await!
MGI Tech will be thrilled to announce its participation in The Festival of Genomics & Biodata, set to take place at ExCeL in London from Wednesday, January 24th, to Thursday, January 25th, 2024. We will invite you to join us at booth number 98 for a transformative experience.
Be sure to mark your calendars and join us for this exciting event. Visit here for more details and to register. We are looking forward to connecting with you at The Festival of Genomics & Biodata, where groundbreaking discoveries and collaborations await!
MGI Tech will be thrilled to announce its participation in The Festival of Genomics & Biodata, set to take place at ExCeL in London from Wednesday, January 24th, to Thursday, January 25th, 2024. We will invite you to join us at booth number 98 for a transformative experience.
Be sure to mark your calendars and join us for this exciting event. Visit here for more details and to register. We are looking forward to connecting with you at The Festival of Genomics & Biodata, where groundbreaking discoveries and collaborations await!
MGI Tech will be thrilled to announce its participation in The Festival of Genomics & Biodata, set to take place at ExCeL in London from Wednesday, January 24th, to Thursday, January 25th, 2024. We will invite you to join us at booth number 98 for a transformative experience.
Be sure to mark your calendars and join us for this exciting event. Visit here for more details and to register. We are looking forward to connecting with you at The Festival of Genomics & Biodata, where groundbreaking discoveries and collaborations await!
About MGI
MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.
MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.
The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.
For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.
About MGI
MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.
MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.
The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.
For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.
About MGI
MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.
MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.
The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.
For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.
About MGI
MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.
MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.
The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.
For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.
Quick Overview of the Event
Key Features:
Inspiring Speakers: Learn from the best in research and clinical breakthroughs.
Cutting-edge Technology: Explore the forefront of genomics and biodata with live demonstrations.
Networking Opportunities: Connect with like-minded individuals, fostering valuable collaborations.
Inclusivity & Impact:
Free for 90% of attendees, the Festival is a platform designed to equip you with new ideas, contacts, and a renewed sense of purpose for the impactful work you do for patients.
Rich Content & Diversity:
With 12 theatres hosting 250 speakers, this event covers a diverse range of topics, ensuring there's something for everyone in the genomics community.
Don't miss this transformative experience. Register now and stay tuned for more updates on The Festival of Genomics & Biodata.
Quick Overview of the Event
Key Features:
Inspiring Speakers: Learn from the best in research and clinical breakthroughs.
Cutting-edge Technology: Explore the forefront of genomics and biodata with live demonstrations.
Networking Opportunities: Connect with like-minded individuals, fostering valuable collaborations.
Inclusivity & Impact:
Free for 90% of attendees, the Festival is a platform designed to equip you with new ideas, contacts, and a renewed sense of purpose for the impactful work you do for patients.
Rich Content & Diversity:
With 12 theatres hosting 250 speakers, this event covers a diverse range of topics, ensuring there's something for everyone in the genomics community.
Don't miss this transformative experience. Register now and stay tuned for more updates on The Festival of Genomics & Biodata.
Quick Overview of the Event
Key Features:
Inspiring Speakers: Learn from the best in research and clinical breakthroughs.
Cutting-edge Technology: Explore the forefront of genomics and biodata with live demonstrations.
Networking Opportunities: Connect with like-minded individuals, fostering valuable collaborations.
Inclusivity & Impact:
Free for 90% of attendees, the Festival is a platform designed to equip you with new ideas, contacts, and a renewed sense of purpose for the impactful work you do for patients.
Rich Content & Diversity:
With 12 theatres hosting 250 speakers, this event covers a diverse range of topics, ensuring there's something for everyone in the genomics community.
Don't miss this transformative experience. Register now and stay tuned for more updates on The Festival of Genomics & Biodata.
Quick Overview of the Event
Key Features:
Inspiring Speakers: Learn from the best in research and clinical breakthroughs.
Cutting-edge Technology: Explore the forefront of genomics and biodata with live demonstrations.
Networking Opportunities: Connect with like-minded individuals, fostering valuable collaborations.
Inclusivity & Impact:
Free for 90% of attendees, the Festival is a platform designed to equip you with new ideas, contacts, and a renewed sense of purpose for the impactful work you do for patients.
Rich Content & Diversity:
With 12 theatres hosting 250 speakers, this event covers a diverse range of topics, ensuring there's something for everyone in the genomics community.
Don't miss this transformative experience. Register now and stay tuned for more updates on The Festival of Genomics & Biodata.
GENOMICS
EXCELLONDON
THE FESTIVAL OF GENOMICS & BIODATA
BIODATA
Share this article :
Share
Sep 10, 2024
MGI Tech Unveils its SEQ ALL landscape at the Future of Omics Conference
Discover insights from the "Future of Omics" event, where leading experts discussed innovations in genomics, proteomics, and metabolomics. Explore key takeaways on advancing research and technology, shaping the future of personalized medicine and healthcare. Join us in celebrating the progress in omics!
Jun 1, 2024
MGI Tech Shares New Data on Core DNEBSEQ Technology and Showcases Latest Sequencing Innovations at ESHG 2024
MGI showcased its latest innovations at the ESHG 2024, highlighting the upgraded StandardMPS 2.0 sequencing chemistry and unveiling the new DNBelab C-TaiM 4 Single-Cell Droplet Generator. European researchers presented advancements in diagnostics, population health, and more.
Apr 27, 2024
MGI Showcases New DNBSEQ-E25 Sequencer & Partners with ABL Diagnostics at ESCMID Global 2024
MGI introduced its portable DNBSEQ-E25 sequencer at ESCMID Global 2024, designed for mobile and efficient genomic sequencing with applications in infectious diseases. Additionally, MGI announced a partnership with ABL Diagnostics to integrate DeepChek® assays into its platforms, broadening NGS solutions for microbiology labs.
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).